The effects of Berberis vulgaris L. and Berberis aristata L. in metabolic syndrome patients: a systematic and meta-analysis study.

The requested reference [4663dc21ef5ccc496cd55504a8df5de1c4186c45] no longer exists in our database. It has been replaced by the current reference: [c904c79186c34593144def3f9deb358238e895e9]

Authors Roshanravan B, Yousefizadeh S, Apaydin Yildirim B, Farkhondeh T, Amirabadizadeh A, Ashrafizadeh M -More
Category Systematic review
JournalArchives of physiology and biochemistry
Year 2020
Links DOI, Pubmed
INTRODUCTION: This meta-analysis study assessed the effects of Berberis vulgaris L. and Berberis aristata L. in patients with metabolic syndrome. METHODS: Data were analysed through "random-effects meta-regression" performance. RESULTS: The findings indicated that LDL was 0.68 and 2.92 lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. The HDL was 0.71-fold higher in the B. aristata L.-treated group versus the controls. The total-cholesterol levels were 1.02 and 2.25 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the matched control groups. The triglyceride levels were 1.35 and 1.16-fold lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. Glucose was 0.96 and 0.54 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the control groups, respectively. CONCLUSION: B. vulgaris L. and B. aristata L. have beneficial effects in patients with metabolic syndrome.
Epistemonikos ID: e227a79bbbbe002311dde1f55f7b78e0999072cc
First added on: Oct 14, 2020